<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We sought to describe <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement as initial presentation of autoimmune <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic diseases</z:e> using a standardized nomenclature </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: A 6-year observational study (1999-2005) was conducted in the University Hospital of Heraklion Crete, a regional referral secondary/tertiary care academic center </plain></SENT>
<SENT sid="2" pm="."><plain>Patients presenting with new neurological symptoms of <z:hpo ids='HP_0011009'>acute</z:hpo>/<z:hpo ids='HP_0011011'>subacute</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> underwent clinical and laboratory screening for systemic <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The diagnosis of an autoimmune rheumatic disorder was based upon the American College of Rheumatology (ACR) classification criteria, whereas for <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (PAPS) we used the Sapporo preliminary criteria </plain></SENT>
<SENT sid="4" pm="."><plain>In order to describe the neurological syndromes we used the ACR nomenclature for <z:e sem="disease" ids="C0752335" disease_type="Disease or Syndrome" abbrv="">neuropsychiatric lupus</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: During this period fourteen patients (ten females and four males) were recorded </plain></SENT>
<SENT sid="6" pm="."><plain>Eight patients had <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), four had primary APS and the remaining two had systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Four out of the eight SLE patients had secondary APS </plain></SENT>
<SENT sid="8" pm="."><plain>Two of them presented with <z:hpo ids='HP_0100022'>movement disorder</z:hpo> (<z:hpo ids='HP_0002072'>chorea</z:hpo>) </plain></SENT>
<SENT sid="9" pm="."><plain>The other two and <z:hpo ids='HP_0000001'>all</z:hpo> four patients with primary APS presented with cerebrovascular disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) </plain></SENT>
<SENT sid="10" pm="."><plain>These six patients comprised the 5.7% of young adults under &lt; 45 years old with <z:hpo ids='HP_0001297'>cerebrovascular accident</z:hpo> admitted over the 6-year period </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: SLE and APS either primary or secondary to SLE were the most common underlying systemic autoimmune <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic diseases</z:e>, in patients presenting with a neurological event of <z:hpo ids='HP_0011009'>acute onset</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Young adults (&lt; 45 years old) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> should undertake screening for SLE/APS </plain></SENT>
</text></document>